Much of the previous work on the association between leptin, resistin, and adiponectin and CKD has produced conflicting results and has originated primarily from studies with small sample sizes and/or unadjusted comparisons between CKD patients and those without CKD. This evidence concerns the gene ADIPOQ and chronic kidney disease.